anti-CD70 mAb (Agrenvec)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD70 mAb (Agrenvec)
Drug Alias Nameanti-CD70 monoclonal antibody (Agrenvec)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCD70 antigen inhibitors
TargetsCD70 antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgrenvec SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgrenvec SL
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A